当前位置: X-MOL 学术Biomater. Sci. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Photosensitizer-induced self-assembly of antigens as nanovaccines for cancer immunotherapy†
Biomaterials Science ( IF 6.6 ) Pub Date : 2018-02-02 00:00:00 , DOI: 10.1039/c7bm01082f
F. Q. Cao 1, 2, 3, 4, 5 , M. M. Yan 1, 2, 3, 4, 5 , Y. J. Liu 1, 2, 3, 4, 5 , L. X. Liu 1, 2, 3, 4, 5 , L. Lu 1, 2, 3, 4, 5 , H. Wang 1, 2, 3, 4, 5 , Ch. Zhang 1, 2, 3, 4, 5 , H. F. Sun 1, 2, 3, 4, 5 , D. L. Kong 1, 2, 3, 4, 5 , G. L. Ma 1, 2, 3, 4, 5
Affiliation  

Herein, the photosensitizer indocyanine green (ICG) is used to induce the self-assembly of antigens to form nanovaccines. Under near-infrared (NIR) laser irradiation, reactive oxygen species can be generated by nanovaccines to disrupt the membranes of endo/lysosomes, which helps to release antigens into the cytosol efficiently, thereby enhancing antigen cross-presentation and anti-cancer immunity. To the best of our knowledge, this study represents the first example of ICG as a biocompatible adjuvant to improve cancer vaccine efficacy.

中文翻译:

光敏剂诱导的抗原自组装作为纳米疫苗用于癌症免疫治疗

在本文中,光敏剂吲哚菁绿(ICG)用于诱导抗原的自组装以形成纳米疫苗。在近红外(NIR)激光照射下,纳米疫苗可产生活性氧,从而破坏内体/溶酶体的膜,从而有助于将抗原有效地释放到胞质溶胶中,从而增强抗原的交叉呈递和抗癌免疫力。据我们所知,本研究代表了ICG作为提高癌症疫苗功效的生物相容性佐剂的第一个实例。
更新日期:2018-02-02
down
wechat
bug